GLP 1R, GIPR, and GCGR: Targets for Obesity and Diabetes Sino Biological The effect of amycretin, a unimolecular glucagon like peptide 1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats eBioMedicine Cagrilintide GLP 1 C Peptide Research Grade Lyophilized Powder BleauGenics Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co morbidities ScienceDirect GLP 1 receptor agonists and next generation incretin based medications: metabolic, cardiovascular, and renal benefits The Lancet